Scientific American series: Emerging trends in immuno-oncology
Bristol Myers Squibb is underwriting a series in partnership with Scientific American to highlight emerging trends in Immuno-Oncology (I-O) and their impact on the future of cancer care.
As part of our focus to better understand cancer biology and the intersection with the immune system, we’ve partnered with Scientific American to underwrite an editorial series highlighting emerging trends in I-O, with a particular focus on biomarkers. The series, which kicked off during the Society for Immunotherapy of Cancer 32nd Annual Meeting, will feature perspectives from Bristol Myers Squibb researchers on the latest challenges and discoveries in I-O.
Using the immune system to fight cancer has been a groundbreaking scientific advancement, but researchers are still working to bring this science to more patients.